CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,138 | +157.1% | 17,893 | +38.9% | 0.12% | +7.1% |
| Q1 2023 | $206,949 | -86.1% | 12,886 | -84.2% | 0.11% | -84.8% |
| Q4 2022 | $1,490,828 | +55.1% | 81,466 | +66.5% | 0.74% | +120.4% |
| Q3 2022 | $961,000 | -12.1% | 48,925 | -16.5% | 0.34% | -29.3% |
| Q2 2022 | $1,093,000 | -3.4% | 58,601 | +13.7% | 0.48% | -9.6% |
| Q1 2022 | $1,131,000 | -0.4% | 51,536 | +28.9% | 0.53% | +178.4% |
| Q4 2021 | $1,136,000 | – | 39,989 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |